Latest Articles
Molecular profiling key to reduce radiation for women with endometrial cancer: Study - thehawk.in
Molecular profiling key to reduce radiation for women with endometrial cancer: Study thehawk.in
Published: May 7, 2025, 4 p.m.
Jill Biden Lands Job Aimed to Improve Women’s Health - NewsBreak: Local News & Alerts
Jill Biden Lands Job Aimed to Improve Women’s Health NewsBreak: Local News & Alerts
Published: May 7, 2025, 3:07 p.m.
Depo Provera Lawsuit Settlement | May 2025 Update - Lawsuit Information Center
Depo Provera Lawsuit Settlement | May 2025 Update Lawsuit Information Center
Published: May 7, 2025, 2:42 p.m.
Common diabetes medication shows promise against prostate cancer - indica News
Common diabetes medication shows promise against prostate cancer indica News
Published: May 7, 2025, 1:25 p.m.
Michelle Ackerley Announces Pregnancy Live After Infertility Battle - Evrim Ağacı
Michelle Ackerley Announces Pregnancy Live After Infertility Battle Evrim Ağacı
Published: May 7, 2025, 12:29 p.m.
Michelle Ackerley Announces Pregnancy Live After Infertility Battle - evrimagaci.org
Michelle Ackerley Announces Pregnancy Live After Infertility Battle evrimagaci.org
Published: May 7, 2025, 12:29 p.m.
Dr. Karli Provost Goldstein Named to 2025 New York Rising Stars List for Fourth Consecutive Year - PharmiWeb.com
Dr. Karli Provost Goldstein Named to 2025 New York Rising Stars List for Fourth Consecutive Year PharmiWeb.com
Published: May 7, 2025, 12:28 p.m.
Dr. Karli Provost Goldstein Named to 2025 New York Rising Stars List for Fourth Consecutive Year - Newswire.com
Dr. Karli Provost Goldstein Named to 2025 New York Rising Stars List for Fourth Consecutive Year Newswire.com
Published: May 7, 2025, noon
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - PR Newswire
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids PR Newswire
Published: May 7, 2025, noon
Linzagolix approved as second at-home treatment option for endometriosis - Pulse Today
Linzagolix approved as second at-home treatment option for endometriosis Pulse Today
Published: May 7, 2025, 11:25 a.m.
Link copied to clipboard!